NasdaqCM - Delayed Quote USD

Estrella Immunopharma, Inc. (ESLAW)

0.0490
-0.0028
(-5.41%)
At close: June 9 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
8,816.3380
7,310.0980
11,114.4020
1,685.3470
733.6930
Operating Income
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Pretax Income
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Tax Provision
1.6250
1.6250
0
0
0
Net Income Common Stockholders
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Diluted NI Available to Com Stockholders
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Total Operating Income as Reported
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Total Expenses
8,816.3380
7,310.0980
11,114.4020
1,685.3470
733.6930
Net Income from Continuing & Discontinued Operation
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Normalized Income
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
EBIT
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
EBITDA
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Net Income from Continuing Operation Net Minority Interest
-8,817.9630
-7,311.7230
-11,114.4020
-1,685.3470
-733.6930
Normalized EBITDA
-8,816.3380
-7,310.0980
-11,114.4020
-1,685.3470
-733.6930
Tax Rate for Calcs
0.0002
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ASBPW Aspire Biopharma Holdings, Inc.
0.0400
-19.84%
 
REVBW Revelation Biosciences, Inc.
0.0119
+6.25%
 
PTIXW Protagenic Therapeutics, Inc.
0.0500
-1.19%
 
LIMNW Liminatus Pharma, Inc.
0.3425
-9.87%
 
ELOX Eloxx Pharmaceuticals, Inc.
0.0001
0.00%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
MLEC Moolec Science SA
6.90
0.00%
 
LIXT Lixte Biotechnology Holdings, Inc.
1.2512
-5.91%
 
TSBX Turnstone Biologics Corp.
0.3659
+1.36%
 
ELAB PMGC Holdings Inc.
2.6400
+21.66%